Health Professionals Follow-up Study

Health Professionals Follow-up Study The Health Professionals Follow-up Study is a long-term prospective cohort study of male health professionals initiated in the mid-1980s to investigate relations among diet, lifestyle, and chronic disease. It links repeated dietary assessments, medical history updates, and biomarker measurements with long-term outcomes such as cardiovascular disease, cancer, and diabetes. The study has informed clinical guidelines and influenced research at institutions such as Harvard School of Public Health, Brigham and Women's Hospital, and Dana–Farber Cancer Institute.

Overview

The project recruits clinicians and tracks incidence of major conditions including myocardial infarction, colorectal cancer, type 2 diabetes mellitus, and Alzheimer's disease through mailed questionnaires, linkage to National Death Index, and medical record validation. Foundational investigators include faculty associated with Harvard Medical School and collaborators from centers like Massachusetts General Hospital, Johns Hopkins Hospital, and the Karolinska Institute. The study interfaces with large consortia such as the Nurses' Health Study and contributes to pooled analyses with groups like the European Prospective Investigation into Cancer and Nutrition.

Methodology

Design features include prospective follow-up, repeated food-frequency questionnaires, and nested case–control analyses using stored biospecimens such as plasma, DNA, and toenail clippings. Analytical methods employ multivariable Cox proportional hazards models, time-varying covariates, and mediation analyses aligned with standards from agencies like the National Institutes of Health and statistical frameworks advanced by researchers at Stanford University and Columbia University. Quality control utilizes validation studies referencing instruments developed by investigators at Tufts University and measurement laboratories at University of California, San Francisco.

Cohort Characteristics

Participants are predominantly male clinicians, including dentists, pharmacists, optometrists, osteopaths, and veterinarians, recruited to represent practicing health professionals across the United States. Baseline characteristics document age distribution, smoking history, alcohol use, and physical activity, with follow-up capturing occupational exposures and retirement-related changes. Subcohorts include blood donors and participants who provided genetic material for genome-wide association studies collaborated with teams at Broad Institute, Wellcome Trust Sanger Institute, and University of Oxford.

Key Findings

Research outputs link dietary patterns and nutrients to disease risk: associations between whole grains, fiber, and lower coronary heart disease risk; relationships of processed meat and red meat with increased colorectal cancer incidence; and effects of trans fats on lipoprotein profiles. The study has clarified roles of aspirin and nonsteroidal anti-inflammatory drugs in colorectal neoplasia prevention, characterized risk factors for venous thromboembolism, and quantified impacts of body mass index on type 2 diabetes mellitus onset. Genetic and epigenetic analyses contributed to discoveries about loci associated with lipid metabolism, blood pressure, and glucose regulation in partnership with consortia including the Global Lipids Genetics Consortium and DIAGRAM.

Impact and Contributions

Findings influenced clinical and public health guidance from organizations such as the American Heart Association, American Cancer Society, and U.S. Preventive Services Task Force. The study's data underpinned dietary recommendations evaluated by panels convened by World Health Organization advisors and informed chemoprevention trials conducted at centers like Mayo Clinic and Fred Hutchinson Cancer Research Center. Methodological innovations in dietary assessment and longitudinal biomarker storage advanced practices adopted by cohorts including the Nurses' Health Study II and the EPIC-Norfolk cohort.

Criticisms and Limitations

Limitations include the homogeneous nature of the cohort—predominantly middle-aged, white, male clinicians—raising questions about generalizability to diverse populations such as those represented in the Multi-Ethnic Study of Atherosclerosis and the Jackson Heart Study. Reliance on self-reported exposures introduces measurement error comparable to challenges documented in cohorts studied by researchers at University of North Carolina at Chapel Hill and University of Minnesota. Residual confounding and changes in clinical practice over decades complicate causal inference in areas intersecting with trials led by groups at National Cancer Institute and Cochrane.